Canopy Growth (CGC) Depreciation & Amortization (CF) (2019 - 2025)

Canopy Growth's (CGC) quarterly Depreciation & Amortization (CF) came in at $3.0 million in Q4 2025, down 4.02% year-on-year from $3.1 million in Q4 2024, and down 3.42% quarter-over-quarter from $3.1 million in Q3 2025.

Canopy Growth (CGC) Depreciation & Amortization (CF) (2019 - 2025) Analysis & Trends

Canopy Growth has disclosed Depreciation & Amortization (CF) across 7 years of filings, most recently posting $3.0 million for Q4 2025.

  • Depreciation & Amortization (CF) for Q4 2025 came in at $3.0 million, down 4.02% year-over-year; the trailing twelve-month figure through Dec 2025 was $13.6 million (up 12.36% YoY), and the FY2025 annual result was $15.0 million, down 28.77% from the prior year.
  • Depreciation & Amortization (CF) came in at $3.0 million for Q4 2025 at Canopy Growth, down from $3.1 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $15.5 million in Q1 2022 to a low of $491145.8 in Q3 2024.
  • The 5-year median for Depreciation & Amortization (CF) is $4.3 million (2024), against an average of $6.4 million.
  • Across the five-year window, Depreciation & Amortization (CF) plunged 93.04% in 2023 and jumped 522.56% in 2025, its largest moves.
  • Canopy Growth's Depreciation & Amortization (CF) stood at $4.4 million in 2021, then tumbled by 74.73% to $1.1 million in 2022, then jumped by 236.38% to $3.7 million in 2023, then dropped by 17.72% to $3.1 million in 2024, then slipped by 4.02% to $3.0 million in 2025.
  • The last three Depreciation & Amortization (CF) figures came in at $3.0 million (Q4 2025), $3.1 million (Q3 2025), and $3.4 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 239.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 119.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 22.60 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 7.20 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 172.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 19.43 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 21.95 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 22.68 Mn
10 Canopy Growth 11.38 Mn -137.31 Mn 15.39 Mn 2.95 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 2.95 Mn
Dec 31, 2025 2.95 Mn
Sep 30, 2025 3.06 Mn
Sep 30, 2025 3.06 Mn
Jun 30, 2025 3.43 Mn
Jun 30, 2025 3.43 Mn
Mar 31, 2025 4.15 Mn
Mar 31, 2025 4.15 Mn
Dec 31, 2024 3.08 Mn
Dec 31, 2024 3.08 Mn
Sep 30, 2024 491,145.78
Sep 30, 2024 491,145.78
Jun 30, 2024 4.15 Mn
Jun 30, 2024 4.15 Mn
Mar 31, 2024 4.37 Mn
Mar 31, 2024 4.37 Mn
Dec 31, 2023 3.74 Mn
Dec 31, 2023 3.74 Mn
Sep 30, 2023 603,457.75
Sep 30, 2023 603,457.75